Contract Assay Development
& Bioconjugation Services

Reader based multiplex lateral flow assays are opening new opportunities for biomarker signatures, structured data capture and algorithmic interpretation. This article explores how candidate markers can be assessed, translated into lateral flow and developed into reliable diagnostic systems with the reader, software, manufacture and regulatory pathway considered from the start.

Performance verification helps assay developers generate controlled, traceable evidence to support analytical performance claims, regulatory submissions and product launch. Fleet Bioprocessing provides CRO support for assay performance verification, claim support, study planning, protocol development, execution and reporting.